Web Results

www.pulmonaryfibrosis.org/life-with-pf/clinical-trials/pipeline

Jul 17, 2020 ... Drug Development Pipeline - PF & IPF. Welcome to the PF Drug Development Pipeline where you can learn about the latest in drug ...

innovations.clevelandclinic.org/Programs/Top-10-Medical-Innovations/Top-10-for-2015/8-New-Medications-for-Idiopathic-Pulmonary-Fibros

There is now new hope for patients with IPF. Two new drugs have been proven in large international studies to significantly slow the progress of IPF. The first oral ...

www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-fibrosis/patients/how-is-pulmonary-fibrosis-treated/medications

Mar 22, 2020 ... Medication for pulmonary fibrosis depends on the type of PF. ... Currently, two drugs are FDA-approved for treatment of idiopathic pulmonary fibrosis (IPF), ... ...

www.ajmc.com/view/emerging-therapeutic-innovations-for-treatment-of-idiopathic-pulmonary-fibrosis

Jan 17, 2020 ... Researchers highlight new therapeutic attempts and potential future ... approaches to treating idiopathic pulmonary fibrosis (IPF), a chronic, fibrosing ... note...

www.astrazeneca.com/media-centre/press-releases/2019/us-fda-grants-saracatinib-orphan-drug-designation-for-idiopathic-pulmonary-fibrosis-18032019.html

Mar 18, 2019 ... The US Food and Drug Administration (FDA) has granted Orphan Drug ... new medicine for the treatment of idiopathic pulmonary fibrosis (IPF), ...

pubmed.ncbi.nlm.nih.gov/30864023

Idiopathic pulmonary fibrosis (IPF) is a progressive and debilitating, scarring lung ... new therapeutic options for IPF and considers the challenges for future drug ...

respiratory-research.biomedcentral.com/articles/10.1186/s12931-019-1161-4

Sep 6, 2019 ... Idiopathic pulmonary fibrosis (IPF) is a progressive disease with a dismal ... These drugs slow decline in lung function and reduce the risk of acute ... Acute ex...

pulmonaryfibrosisnews.com/2020/01/03/top-10-pulmonary-fibrosis-stories-of-2019

Jan 3, 2020 ... 10 – “AstraZeneca Turns to Artificial Intelligence to Speed Discovery of New Medicines for IPF”. AstraZeneca announced a collaboration with ...

www.pulmonologyadvisor.com/home/topics/restrictive-lung-disease/new-idiopathic-pulmonary-fibrosis-treatment-safe-likely-effective

Jan 24, 2019 ... “Although pirfenidone and nintedanib represent a significant improvement in the treatment of IPF, they do not represent a cure and both drugs ...

www.mayoclinic.org/medical-professionals/pulmonary-medicine/news/anti-fibrotic-therapy-in-the-treatment-of-ipf-ongoing-concerns-and-current-practices/mac-20438808

Pirfenidone, a well-known anti-fibrotic drug already approved outside the U.S., ... At this time, use of both anti-fibrotic drugs is limited to the diagnosis of IPF but ...